Financial Performance - Net Investment Income (NII) for the quarter ended September 30, 2025, was $79,350,000, a decrease of 11.7% from $89,877,000 in the same quarter of 2024[2] - Net Income applicable to common shareholders was $48,087,000, compared to a loss of $165,069,000 in the same quarter of 2024[2] - Total interest income (excluding PIK interest income) for the three months ended September 30, 2025, was $136,978,000, down from $151,471,000 for the same period in 2024, a decrease of about 9.6%[25] - Net investment income for the three months ended September 30, 2025, was $79,350,000, compared to $89,877,000 for the same period in 2024, reflecting a decline of approximately 11.7%[25] - The net increase in net assets resulting from operations applicable to common stockholders for the three months ended September 30, 2025, was $48,087,000, compared to a loss of $165,069,000 for the same period in 2024[25] - Total operating expenses decreased to $78,274,000 for the three months ended September 30, 2025, down from $106,431,000 for the same period in 2024, a reduction of about 26.4%[25] - The diluted net increase from operations applicable to common stockholders was $0.08 for the three months ended September 30, 2025, compared to a diluted net decrease of $0.38 for the same period in 2024[26] Asset and Investment Overview - Total assets decreased to $6,641,870,000 from $7,592,705,000 year-over-year, reflecting a decline of 12.5%[2] - Total investments at fair value decreased to $6,513,456,000 as of September 30, 2025, from $6,673,516,000 as of June 30, 2025, representing a decline of approximately 2.4%[23] - Control investments at fair value increased to $3,710,632,000 as of September 30, 2025, from $3,696,367,000 as of June 30, 2025, reflecting a growth of about 0.4%[23] - The first lien senior secured loans increased to 71.1% of the investment portfolio, up 701 basis points from June 2024[6] - The company primarily invests in private, middle-market companies in the U.S. with annual revenues of less than $750 million and enterprise values of less than $1 billion[28] - The typical investment involves a senior and secured loan of less than $250 million, focusing on capital for refinancings, acquisitions, and growth initiatives[28] - The company also invests in senior and secured debt and controlling equity positions in real estate investment trusts (REITs), generating current yields from developed properties[30] Cash and Distributions - The company declared monthly cash distributions of $0.0450 per share for November 2025, December 2025, and January 2026, totaling approximately $4.6 billion in cumulative distributions since inception[3] - Cash and cash equivalents increased to $86,541,000 as of September 30, 2025, from $50,788,000 as of June 30, 2025, marking a significant increase of approximately 70.5%[23] - The dividend payable decreased to $21,288,000 as of September 30, 2025, from $28,836,000 as of June 30, 2025, a decline of approximately 26.4%[23] - Total distributions to common stockholders were $0.14 per share for the three months ended September 30, 2025, down from $0.18 per share in the same period of 2024[26] Debt and Financing - The weighted average cost of unsecured debt financing was 4.54%, reflecting an increase of 0.02% from the previous quarter[17] - The company has a total of $2.1 billion in revolving credit facility commitments, with $2.4 million remaining of debt maturing during calendar year 2025[13] Net Asset Value - The net asset value (NAV) per common share decreased to $6.45 from $8.10 year-over-year[2] - The net asset value per common share as of September 30, 2025, was $6.45, down from $6.56 as of June 30, 2025, indicating a decrease of approximately 1.7%[23] - Net asset value per common share decreased from $8.74 at the beginning of the period to $6.45 at the end of the period, representing a decline of approximately 26.2%[26] Future Outlook - Forward-looking statements made by the company are subject to various risks and uncertainties, and actual results may vary materially from those projected[35] - The internal rate of return (IRR) calculations are gross of general expenses and are historical results, not necessarily indicative of future performance[27] Corporate Events - The company will host an earnings call on November 7, 2025, at 9:00 a.m. Eastern Time[21]

COLUMBUS, Ohio, USA – November 6, 2025 – Mettler-Toledo International Inc. (NYSE: MTD) today announced third quarter results for 2025. Provided below are the highlights: Third Quarter Results Patrick Kaltenbach, President and Chief Executive Officer, stated, "Our third quarter results were strong and reflected very good growth, especially in Industrial. I am very pleased with our team's strong execution as we leverage our Spinnaker sales and marketing program and innovative product portfolio to drive growth ...

MarketWise Reports Net Revenue of $81.3 Million and Net Income of $17.9 Million for Third Quarter 2025; Third Quarter Billings Increased 30% YoY; Announced Quarterly and Special Dividend Totaling $0.40 per Class A Share, for Total FY 2025 Dividends of $1.90 Per Share, or a 13% Cash Yield; Provides Preliminary Targets for FY 2026, Including a 50% Planned Increase in CFFO BALTIMORE, MD -- (GLOBE NEWSWIRE)—MarketWise, Inc. (NASDAQ: MKTW) ("MarketWise" or the "Company"), a leading multi-brand digital subscripti ...

Financial Performance - The company reported a significant increase in revenue, reaching $150 million, representing a 25% year-over-year growth[8] - The company anticipates a revenue growth of 20% for the next quarter, projecting $180 million in revenue[8] - New product launches are expected to contribute an additional $30 million in revenue over the next fiscal year[8] User Engagement - User engagement metrics improved, with a 15% increase in active users, totaling 10 million users[8] Market Expansion - The company is expanding its market presence in Europe, targeting a 10% market share by the end of the year[8] Strategic Initiatives - A strategic acquisition was completed, enhancing the company's technology capabilities and expected to generate $5 million in cost savings annually[8] - The company is investing $10 million in research and development for new technologies, including AI[8] Operating Expenses - Operating expenses increased by 12%, primarily due to higher marketing costs associated with new product launches[8] Financial Position - The company has maintained a strong cash position, with $50 million in cash and cash equivalents[8] Future Risks - Future risks include potential economic downturns and increased competition in the digital media space[11]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 16 Lincoln Square, Gettysburg, Pennsylvania 17325 (Address of principal executive offices) (Zip Code) OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number 1-35015 ACNB ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35703 PUMA BIOTECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 77-0683487 (State or other jurisdiction of incorporation or organization) Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTIO ...

Financial Performance - For Q3 2025, Consolidated Edison reported total operating revenues of $4,530 million, a 10.7% increase from $4,092 million in Q3 2024[17]. - Net income for Q3 2025 was $688 million, up 17% from $588 million in Q3 2024, resulting in a diluted net income per share of $1.90[17][18]. - For the nine months ended September 30, 2025, total operating revenues reached $12,924 million, a 11.5% increase compared to $11,587 million for the same period in 2024[17]. - Operating income for the nine months ended September 30, 2025, was $2,448 million, reflecting a 11.6% increase from $2,193 million in 2024[17]. - Net income for the nine months ended September 30, 2025, was $1,606 million, up 13.3% from $1,417 million in the same period of 2024[24]. - Total comprehensive income for Q3 2025 was $639 million, compared to $537 million in Q3 2024[24]. - The company’s comprehensive income for the nine months ended September 30, 2025, was $1,598 million, an increase from $1,417 million in 2024[24]. Operating Expenses and Income - The company’s total operating expenses for Q3 2025 were $3,562 million, a 10.3% increase from $3,230 million in Q3 2024[17]. - Total operating expenses for Q3 2025 were $3,267 million, a 10.4% increase from $2,959 million in Q3 2024[23]. - The total operating income for CECONY for the three months ended September 30, 2025, was $914 million, compared to $803 million in 2024, representing a growth of 13.8%[121]. - The total operating income for the nine months ended September 30, 2025, was $10,476 million, compared to $9,364 million for the same period in 2024, indicating an increase of 11.8%[17]. Cash Flow and Assets - The company reported net cash flows from operating activities of $3,320 million for the nine months ended September 30, 2025, compared to $2,304 million in 2024[19]. - Total assets as of September 30, 2025, were $71,844 million, an increase from $70,562 million at the end of 2024[20]. - The balance of cash and temporary cash investments decreased to $181 million as of September 30, 2025, from $1,324 million at the end of 2024[20]. - Cash flows from operating activities for the nine months ended September 30, 2025, were $3,111 million, an increase from $2,087 million in 2024[25]. - Total current liabilities decreased to $5,079 million as of September 30, 2025, down from $6,433 million at the end of 2024[21]. Shareholder Equity and Dividends - The balance of shareholders' equity increased to $24,168 million as of September 30, 2025, up from $21,962 million at the end of 2024[21]. - The company issued common stock dividends of $0.85 per share, totaling $295 million for the nine months ended September 30, 2025[22]. - The average number of shares outstanding for basic shares increased to 360.7 million in Q3 2025 from 346.2 million in Q3 2024[17]. Debt and Liabilities - Consolidated Edison’s interest expense for the nine months ended September 30, 2025, was $922 million, compared to $883 million in 2024[17]. - Long-term debt increased slightly to $24,909 million as of September 30, 2025, compared to $24,651 million at the end of 2024[21]. - Total current liabilities decreased by 20% from $5,559 million in December 2024 to $4,458 million in September 2025[27]. - CECONY's regulatory liabilities decreased from $5,546 million in December 31, 2024, to $5,069 million as of September 30, 2025[61]. Regulatory and Rate Changes - CECONY's electric base rate changes for the three-year period from January 2026 to December 2028 include increases of $222 million in Year 1, $473 million in Year 2, and $329 million in Year 3[45]. - CECONY's gas base rate changes include a decrease of $46 million in Year 1, followed by increases of $170 million in Year 2 and $93 million in Year 3[47]. - The Joint Proposal for CECONY's electric and gas rate plans is subject to approval by the New York State Public Service Commission[44]. Environmental and Legal Liabilities - The estimated aggregate undiscounted potential liability for the investigation and remediation of environmental contaminants at Con Edison’s manufactured gas plant sites is up to $3,391 million, while for CECONY it is $3,237 million[88]. - Con Edison and CECONY have accrued estimated liabilities for asbestos suits totaling $8 million and $7 million, respectively, as of September 30, 2025, consistent with the previous year[91]. - For the nine months ended September 30, 2025, Con Edison incurred investigation and remediation costs of $12 million, down from $27 million in 2024, while CECONY's costs were $11 million compared to $27 million in the previous year[87]. Tax Expenses - The income tax expense for Con Edison was $202 million for the three months ended September 30, 2025, compared to $133 million in 2024, reflecting an effective tax rate of 22.7%[97]. - CECONY's income tax expense for the same period was $187 million, up from $119 million in 2024, also with an effective tax rate of 22.7%[97]. - The effective tax rate for CECONY increased to 22.4% in 2025 from 17.5% in 2024, indicating a significant rise in tax burden[100]. Capital Expenditures - Capital expenditures for CECONY's electric operations are projected at $4,550 million in Year 1, $4,474 million in Year 2, and $4,712 million in Year 3[45]. - Capital expenditures for gas operations are estimated at $1,093 million in Year 1, $1,057 million in Year 2, and $1,065 million in Year 3[47]. - CECONY plans to implement a low carbon fuels pilot program for steam generation, with an estimated cost of $332 million for four steam decarbonization projects[53].

Financial Performance - Revenues of $76.5 million in Q3 2025, up 4.6% from $73.1 million in Q3 2024[61] - Operating income of $7.6 million in Q3 2025, up 16.5% from $6.5 million in Q3 2024[61] - Net income of $6.1 million in Q3 2025, up 6.3% from $5.7 million in Q3 2024[61] - Adjusted EBITDA of $19.1 million in Q3 2025, up 7.9% from $17.7 million in Q3 2024[61] - Revenues increased by $6.9 million, or 3%, to $224.4 million for the nine months ended September 30, 2025, compared to $217.4 million for the same period in 2024[80] - Subscription revenues rose by $7.5 million, or 4%, to $216.6 million, representing 97% of total revenues for the nine months ended September 30, 2025[81] - Net income for the nine months ended September 30, 2025, was $15.8 million, compared to $15.1 million for the same period in 2024, with EPS increasing to $0.52 from $0.50[88] - Adjusted EBITDA was $52.9 million for the nine months ended September 30, 2025, compared to $50.6 million for the same period in 2024[88] Revenue Composition - Subscription revenues increased by $4.0 million, or 6%, while professional services revenues decreased by $0.6 million, or 19% in Q3 2025 compared to Q3 2024[69] Cost and Expenses - Cost of revenues increased by $2.0 million, or 8%, to $26.5 million in Q3 2025, with cost of revenues as a percentage of revenues rising to 35% from 33%[70] - General and administrative expenses decreased by $1.2 million, or 13%, to $7.3 million in Q3 2025, representing 10% of revenues compared to 12% in Q3 2024[73] - Cost of revenues increased by $5.6 million, or 8%, to $78.4 million, with cost of revenues as a percentage of revenues rising to 35% from 33%[81] Cash Flow and Investments - Net cash provided by operating activities increased by $3.6 million to $50.1 million during the nine months ended September 30, 2025[95] - Net cash used in investing activities was $27.0 million for the nine months ended September 30, 2025, compared to $25.9 million for the same period in 2024[96] - Capital expenditures were $7.5 million in Q3 2025, compared to $6.8 million in Q3 2024, reflecting increased investment in product development[66] Shareholder Returns - The company repurchased 905,786 shares of common stock at an aggregate fair value of $25.0 million during the nine months ended September 30, 2025[103] Financial Position - The company has a working capital of $35.1 million as of September 30, 2025, down from $37.4 million at December 31, 2024[98] - The company has a $50.0 million revolving credit facility with no outstanding borrowings as of September 30, 2025[99] - The Company is in compliance with all covenants under its revolving credit facility as of September 30, 2025[105] - The Company had no outstanding debt as of September 30, 2025, but may face interest rate market risk with future borrowings[107] Cash and Investment Risks - Cash and investment balances were $92.6 million as of September 30, 2025, with a hypothetical 10% decrease in interest rates potentially reducing annual interest income by $0.3 million[107] - The Company is exposed to foreign currency risks related to revenues and operating expenses in currencies such as the Canadian dollar, New Zealand dollar, and Australian dollar[108] - The Company has not entered into foreign currency hedging contracts to date but may consider doing so in the future[109] - The Company's investment strategy focuses on highly rated securities to minimize principal loss risk, with limits on credit exposure to single issuers[110] - The investment portfolio includes strategic investments in early-stage healthcare technology companies to expand the ecosystem[111] - The Company may experience volatility in its financial statements due to changes in market prices and impairments of strategic investments[111] - Future results may differ materially from projected market risks due to actual market developments[112] Taxation - The effective tax rate was 26% for Q3 2025, compared to 23% for Q3 2024[76] - The company expects to record sublease income of approximately $0.8 million during the last three months of 2025 and $3.2 million annually thereafter[62]

Financial Performance - Revenue for Q3 2025 increased by 17.0% to $572.8 million, compared to $489.6 million in Q3 2024[4] - Net income for Q3 2025 was $49.8 million, an increase of 8.9% from $45.8 million in Q3 2024[5] - Adjusted EBITDA rose by 17.1% to $118.9 million in Q3 2025, up from $101.6 million in Q3 2024[5] - Revenue for the nine months ended September 30, 2025, was $1,624,337, representing a 13.2% increase from $1,435,151 in 2024[25] - Net income for the nine months ended September 30, 2025, was $136,658, a decrease of 8.8% from $149,097 in 2024[34] - Basic and diluted earnings per share for the nine months ended September 30, 2025, was $1.03, compared to $1.32 in 2024[28] - Net income for Q3 2025 was $49,822, representing 8.7% of revenue, compared to $45,759 (9.3%) in Q3 2024[44] - Adjusted net income attributable to the company for Q3 2025 was $49,929, or $0.39 per share, compared to $44,306 ($0.37) in Q3 2024[49] Operational Metrics - Patient visits totaled 3,557,697 in Q3 2025, averaging 55,589 visits per day, a 9.2% increase from Q3 2024[5] - Total patient visits for the nine months ended September 30, 2025, were 10,282,385, a 6.8% increase compared to 9,628,515 in 2024[38] - The number of occupational health centers increased to 628 by the end of September 2025, up from 549 in 2024, with 72 centers acquired during the period[38] - The company operated 413 onsite health clinics by the end of September 2025, compared to 156 in 2024[38] - Revenue per visit for workers' compensation increased by 4.7% to $211.82 in Q3 2025 from $202.29 in Q3 2024[36] Financial Position - The company reported a cash balance of $49.9 million and reduced net leverage to 3.6x as of September 30, 2025[8] - Total assets increased to $2,843,930 as of September 30, 2025, from $2,521,164 at the end of 2024[32] - Cash at the end of the period decreased to $49,941 from $183,255 at the beginning of the period[32] - Current liabilities increased slightly to $312,650 as of September 30, 2025, compared to $307,186 at the end of 2024[32] Expenses and Costs - Total costs and expenses rose by 14.3% to $1,360,024 for the nine months ended September 30, 2025, from $1,189,759 in 2024[25] - Interest expense surged by 287.4% to $82,424 in 2025, compared to $21,275 in 2024[25] - Interest expense for Q3 2025 was $28,683, which is 5.0% of revenue, compared to $21,369 (4.4%) in Q3 2024[44] - Cash paid for interest increased significantly to $94,135 in 2025 from $34,221 in 2024[34] Guidance and Future Expectations - Concentra raised its full-year 2025 revenue guidance to a range of $2.145 billion to $2.160 billion[17] - The company expects full-year 2025 adjusted EBITDA to be in the range of $425 million to $430 million[54] - The anticipated net income attributable to the company for 2025 is projected between $156 million and $161 million[54] Shareholder Actions - A cash dividend of $0.0625 per share was declared, payable on December 9, 2025[10] - The company authorized a share repurchase program of up to $100 million, set to expire on December 31, 2027[12] Capital Expenditures - Capital expenditures for 2025 are expected to be in the range of $80 million to $90 million[17] Other Financial Activities - The company reported a loss on early retirement of debt amounting to $875 in 2025, with no such loss reported in 2024[25] - The company reported a net cash used in investing activities of $394,725 for the nine months ended September 30, 2025, compared to $54,579 in 2024[34] - Separation transaction costs for Q3 2025 were $1,025, representing 0.2% of revenue[44] - The company incurred $1,181 in acquisition costs related to Nova and Pivot Onsite Innovations in Q3 2025[44]

Exhibit 99.1 MidCap Financial Investment Corporation Reports Financial Results for the Quarter Ended September 30, 2025 Results for the Quarter Ended September 30, 2025 and Other Recent Highlights: 1 • Net investment income per share for the quarter was $0.38, compared to $0.39 for the quarter ended June 30, 2025 • Net asset value per share as of the end of the quarter was $14.66, compared to $14.75 as of June 30, 2025, a decrease of 0.6% • New investment commitments made during the quarter totaled $138 mil ...